Search Results - "Doucet, Robert"

Predictive Parameters of CyberKnife Fiducial-less (XSight Lung) Applicability for Treatment of Early Non-Small Cell Lung Cancer: A Single-Center Experience by Bahig, Houda, MD, Campeau, Marie-Pierre, MD, Vu, Toni, MD, Doucet, Robert, MSc, Béliveau Nadeau, Dominic, MSc, Fortin, Bernard, MD, MSc, Roberge, David, MD, Lambert, Louise, MD, Carrier, Jean-François, PhD, Filion, Edith, MD

“…Purpose To determine which parameters allow for CyberKnife fiducial-less tumor tracking in stereotactic body radiation therapy (SBRT) for early-stage non-small…”
Get full text

Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis by Bahig, Houda, Filion, Edith, Vu, Toni, Roberge, David, Lambert, Louise, Bouchard, Myriam, Lavoie, Caroline, Doucet, Robert, Nadeau, Dominic Béliveau, Chalaoui, Jean, Campeau, Marie-Pierre

“…The aim of this study is to report outcomes and prognostic factors for early stage non-small cell lung cancer treated with patient-adapted Cyberknife…”
Get full text

Long-term results of radiosurgery for cerebral arteriovenous malformations by Lecavalier-Barsoum, Magali, Roy, Daniel, Doucet, Robert, Fortin, Bernard, Lambert, Carole, Moumdjian, Robert, Bahary, Jean-Paul

“…Stereotactic radiosurgery (SRS) is known to safely result in a high obliteration rate for small and medium sized arteriovenous malformations (AVM). To evaluate…”
Get more information

A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy by Tonneau, Marion, Richard, Corentin, Routy, Bertrand, Campeau, Marie-Pierre, Vu, Toni, Filion, Edith, Roberge, David, Mathieu, Dominique, Doucet, Robert, Beliveau-Nadeau, Dominic, Bahig, Houda

“…•The main prognostic factor for LR and RR risks was central location.•After a first recurrence, OS was similar for ultra-central, central, and peripheral…”
Get full text

42: A Competing Risk Analysis of Prognostic Factors for Local and Regional Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy by Tonneau, Marion, Richard, Corentin, Routy, Bertrand, Campeau, Marie-Pierre, Vu, Toni, Filion, Edith, Roberge, David, Mathieu, Dominique, Doucet, Robert, Beliveau-Nadeau, Dominic, Bahig, Houda

Get full text

Comparing local control and distant metastasis in NSCLC patients between CyberKnife and conventional SBRT by Diamant, André, Heng, Veng Jean, Chatterjee, Avishek, Faria, Sergio, Bahig, Houda, Filion, Edith, Doucet, Robert, Khosrow-Khavar, Farzin, Naqa, Issam El, Seuntjens, Jan

“…•CyberKnife delivers higher dose outside PTV compared to conventional SBRT (VMAT/CRT).•Higher dose outside the PTV is associated with reduced distant…”
Get full text

95 Dosimetric Comparison of HDR Brachytherapy and VMAT for Accelerated Partial Breast Irradiation (APBI) by Bernard, Andrée-Anne, Mateus, Chrystian Quintero, Vu, Toni, Doucet, Robert, Fortin, Israël

Get full text

Planning Trade-offs for SABR in Patients With 4 to 10 Metastases: A Substudy of the SABR-COMET-10 Randomized Trial by Ashram, Samaher, Bahig, Houda, Barry, Aisling, Blanchette, Denise, Celinksi, Anders, Chung, Peter, Darko, Johnson, Donath, David, Doucet, Robert, Erickson, Abigail, Giuliani, Meredith, Gopaul, Darin, Hipwell, Scott, Javor, Joanna, Kuk, Joda, Lindsay, Patricia, Millman, Barbara, Oliver, Michael, Pearce, Andrew, Russell, Catherine, Senthi, Sashendra, Vu, Toni, Warner, Andrew, Gaede, Stewart, Palma, David A.

Get full text

Technical note: Consistency of IAEA's TRS‐483 and AAPM's extended TG‐51 protocols for clinical reference dosimetry of the CyberKnife M6 machine by Duchaine, Jasmine, Markel, Daniel, Ley, Jean‐Luc, Béliveau‐Nadeau, Dominique, Zerouali, Karim, Doucet, Robert, Bouchard, Hugo

“…Background While IAEA's TRS‐483 code of practice is adapted for the calibration of CyberKnife machines, AAPM's TG‐51 is still the protocol recommended by the…”
Get full text

184: Reproducibility of a Non-Invasive System for Ocular Immobilization in Robotic Stereotactic Radiotherapy of Ocular Melanoma by Iskanderani, Omar, Béliveau-Nadeau, Dominique, Doucet, Robert, Coulombe, Geneviève, Deborah, Pascale, Roberge, David

Get full text

160: Limiting Chest Wall Toxicity by Adapting the Dose Schedule and Dose Constraints in SBRT for Early-Stage Lung Cancer by Jumeau, Raphael, Filion, Edith, Bahig, Houda, Vu, Toni, Lambert, Louise, Roberge, David, Doucet, Robert, Campeau, Marie-Pierre

Get full text

A dosimetric parameter to limit chest wall toxicity in SABR of NSCLC by Jumeau, Raphaël, Filion, Édith, Bahig, Houda, Vu, Toni, Lambert, Louise, Roberge, David, Doucet, Robert, Campeau, Marie-Pierre

“…Chest wall (CW) toxicity (rib fracture and/or pain) is a recognized complication of stereotactic ablative radiotherapy (SABR) for non-small-cell lung cancer…”
Get full text

Large-scale dosimetric assessment of Monte Carlo recalculated doses for lung robotic stereotactic body radiation therapy by Heng, Veng Jean, Renaud, Marc-André, Zerouali, Karim, Doucet, Robert, Diamant, André, Bahig, Houda, DeBlois, François, Seuntjens, Jan

“…•Monte Carlo recalculation of 219 CyberKnife lung SBRT plans.•Ray-Tracing algorithm is inaccurate and severely compromises target coverage.•Recalculated…”
Get full text

151: Does MID-Treatment CBCT-Guided Patient Repositioning During Lung VMAT Impact Target Coverage? by Mathieu, Dominique, Campeau, Marie-Pierre, Doucet, Robert, Zerouali, Karim, Bedwani, Stéphane, Bahig, Houda, Lambert, Louise, Thuc Vu, Thi Trinh, Roberge, David, Filion, Édith

Get full text

3: Laryngeal Motion Dynamics using 4D-Computed Tomography and Dynamic Magnetic Resonance Imaging by Bahig, Houda, Nguyen-Tan, Félix P, Filion, Edith, Roberge, David, Thanomsack, Pensavan, Doucet, Robert, Blais, Danis, Lambert, Louise

Get full text

Reproducibility of a Noninvasive System for Eye Positioning and Monitoring in Stereotactic Radiotherapy of Ocular Melanoma by Iskanderani, Omar, Béliveau-Nadeau, Dominique, Doucet, Robert, Coulombe, Geneviève, Pascale, Deborah, Roberge, David

“…Purpose: Our preferred treatment for juxtapapillary choroidal melanoma is stereotactic radiotherapy. We aim to describe our immobilization system and quantify…”
Get full text

Planning Trade-offs for Stereotactic Ablative Radiotherapy in Patients with 4-10 Metastases: A Sub-study of the SABR-COMET-10 randomized trial by Ashram, Samaher, Bahig, Houda, Barry, Aisling, Blanchette, Denise, Celinksi, Anders, Chung, Peter, Darko, Johnson, Donath, David, Doucet, Robert, Erickson, Abigail, Giuliani, Meredith, Gopaul, Darin, Hipwell, Scott, Javor, Joanna, Kuk, Joda, Lindsay, Patricia, Millman, Barbara, Oliver, Michael, Pearce, Andrew, Russell, Catherine, Senthi, Sashendra, Vu, Toni, Warner, Andrew, Gaede, Stewart, Palma, David A

“…The use of stereotactic ablative radiotherapy (SABR) for metastases often involves trade-offs, balancing adequate target coverage with the need to maintain a…”
Get full text

CD36(+)-dendritic epidermal cells: a putative actor in the cutaneous immune system by Rouabhia, M, Jobin, N, Doucet, Jr, R, Bergeron, J, Auger, F A

“…In the present study we have investigated by indirect immunofluorescence staining and mixed lymphocyte reaction methods, the localization, distribution,…”
Get full text

The impacts of mid‐treatment CBCT‐guided patient repositioning on target coverage during lung VMAT by Mathieu, Dominique, Campeau, Marie‐Pierre, Bedwani, Stéphane, Roberge, David, Doucet, Robert, Zerouali, Karim, Bahig, Houda, Vu, Toni, Lambert, Louise, Masucci, Laura, Filion, Edith

“…Introduction The purpose of this study is quantify intrafraction motion (IFM) during lung volumetric‐modulated arc therapy (VMAT) and evaluate the impact of…”
Get full text

Larynx motion considerations in partial larynx volumetric modulated arc therapy for early glottic cancer by Bahig, Houda, Nguyen‐Tan, Phuc Félix, Filion, Édith, Roberge, David, Thanomsack, Pensavan, Guise, Jacques, Blais, Danis, Doucet, Robert, Létourneau‐Guillon, Laurent, Lambert, Louise

“…Introduction To assess laryngeal motion in early glottic cancer in order to determine safe margins for partial larynx volumetric modulated arc therapy…”
Get full text